Towards quantum computing for clinical trial design and optimization: A perspective on new opportunities and challenges

• URL: http://arxiv.org/abs/2404.13113v1
• Date: Fri, 19 Apr 2024 18:00:25 GMT
• Title: Towards quantum computing for clinical trial design and optimization: A perspective on new opportunities and challenges
• Abstract summary: This paper examines the current challenges faced in clinical trial design and optimization. The focus is on three critical aspects: clinical trial simulations, site selection, and cohort identification.
• Score: 0.250217476520467
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Clinical trials are pivotal in the drug discovery process to determine the safety and efficacy of a drug candidate. The high failure rates of these trials are attributed to deficiencies in clinical model development and protocol design. Improvements in the clinical drug design process could therefore yield significant benefits for all stakeholders involved. This paper examines the current challenges faced in clinical trial design and optimization, reviews established classical computational approaches, and introduces quantum algorithms aimed at enhancing these processes. Specifically, the focus is on three critical aspects: clinical trial simulations, site selection, and cohort identification. This study aims to provide a comprehensive framework that leverages quantum computing to innovate and refine the efficiency and effectiveness of clinical trials.

Related papers

• Medical Reasoning in the Era of LLMs: A Systematic Review of Enhancement Techniques and Applications [59.721265428780946]
  Large Language Models (LLMs) in medicine have enabled impressive capabilities, yet a critical gap remains in their ability to perform systematic, transparent, and verifiable reasoning.<n>This paper provides the first systematic review of this emerging field.<n>We propose a taxonomy of reasoning enhancement techniques, categorized into training-time strategies and test-time mechanisms.
  arXiv  Detail & Related papers  (2025-08-01T14:41:31Z)
• Deep Learning-based Prediction of Clinical Trial Enrollment with Uncertainty Estimates [1.7099366779394252]
  Accurately predicting patient enrollment, a key factor in trial success, is one of the primary challenges during the planning phase.<n>We propose a novel deep learning-based method to address this critical challenge.<n>We show that the proposed method can effectively predict the number of patients enrolled at a number of sites for a given clinical trial.
  arXiv  Detail & Related papers  (2025-07-31T14:47:16Z)
• SECRET: Semi-supervised Clinical Trial Document Similarity Search [22.008566744843353]
  We present a novel method to identify similar historical trials by summarizing clinical trial protocols and searching for similar trials based on a query trial's protocol.<n>Our approach significantly outperforms all baselines, achieving up to a 78% improvement in recall@1 and a 53% improvement in precision@1 over the best baseline.
  arXiv  Detail & Related papers  (2025-05-16T01:34:16Z)
• From Bench to Bedside: A Review of Clinical Trials in Drug Discovery and Development [16.983261704407784]
  Clinical trials are an indispensable part of the drug development process. The paper addresses the major challenges encountered in clinical trials, such as ethical issues, subject recruitment difficulties, diversity and representativeness concerns. The article looks forward to the future of clinical trials, particularly the impact of emerging therapies such as gene therapy and immunotherapy on trial design.
  arXiv  Detail & Related papers  (2024-12-12T15:46:43Z)
• Advancing clinical trial outcomes using deep learning and predictive modelling: bridging precision medicine and patient-centered care [0.0]
  Deep learning and predictive modelling have emerged as transformative tools for optimizing clinical trial design, patient recruitment, and real-time monitoring. This study explores the application of deep learning techniques, such as convolutional neural networks [CNNs] and transformerbased models, to stratify patients. Predictive modelling approaches, including survival analysis and time-series forecasting, are employed to predict trial outcomes, enhancing efficiency and reducing trial failure rates.
  arXiv  Detail & Related papers  (2024-12-09T23:20:08Z)
• TrialBench: Multi-Modal Artificial Intelligence-Ready Clinical Trial Datasets [57.067409211231244]
  This paper presents meticulously curated AIready datasets covering multi-modal data (e.g., drug molecule, disease code, text, categorical/numerical features) and 8 crucial prediction challenges in clinical trial design. We provide basic validation methods for each task to ensure the datasets' usability and reliability. We anticipate that the availability of such open-access datasets will catalyze the development of advanced AI approaches for clinical trial design.
  arXiv  Detail & Related papers  (2024-06-30T09:13:10Z)
• Language Interaction Network for Clinical Trial Approval Estimation [37.60098683485169]
  We introduce the Language Interaction Network (LINT), a novel approach that predicts trial outcomes using only the free-text descriptions of the trials. We have rigorously tested LINT across three phases of clinical trials, where it achieved ROC-AUC scores of 0.770, 0.740, and 0.748.
  arXiv  Detail & Related papers  (2024-04-26T14:50:59Z)
• TrialDura: Hierarchical Attention Transformer for Interpretable Clinical Trial Duration Prediction [19.084936647082632]
  We propose TrialDura, a machine learning-based method that estimates the duration of clinical trials using multimodal data. We encode them into Bio-BERT embeddings specifically tuned for biomedical contexts to provide a deeper and more relevant semantic understanding. Our proposed model demonstrated superior performance with a mean absolute error (MAE) of 1.04 years and a root mean square error (RMSE) of 1.39 years compared to the other models.
  arXiv  Detail & Related papers  (2024-04-20T02:12:59Z)
• PyTrial: Machine Learning Software and Benchmark for Clinical Trial Applications [49.69824178329405]
  PyTrial provides benchmarks and open-source implementations of a series of machine learning algorithms for clinical trial design and operations. We thoroughly investigate 34 ML algorithms for clinical trials across 6 different tasks, including patient outcome prediction, trial site selection, trial outcome prediction, patient-trial matching, trial similarity search, and synthetic data generation. PyTrial defines each task through a simple four-step process: data loading, model specification, model training, and model evaluation, all achievable with just a few lines of code.
  arXiv  Detail & Related papers  (2023-06-06T21:19:03Z)
• AutoTrial: Prompting Language Models for Clinical Trial Design [53.630479619856516]
  We present a method named AutoTrial to aid the design of clinical eligibility criteria using language models. Experiments on over 70K clinical trials verify that AutoTrial generates high-quality criteria texts.
  arXiv  Detail & Related papers  (2023-05-19T01:04:16Z)
• Improved clinical data imputation via classical and quantum determinantal point processes [1.3749490831384268]
  Imputing data is a critical issue for machine learning practitioners. Here we propose novel imputation methods based on determinantal point processes. We demonstrate competitive results with up to ten qubits for small-scale imputation tasks.
  arXiv  Detail & Related papers  (2023-03-31T08:54:46Z)
• Artificial Intelligence for In Silico Clinical Trials: A Review [41.85196749088317]
  In silico trials are clinical trials conducted digitally through simulation and modeling. This article systematically reviews papers under three main topics: clinical simulation, individualized predictive modeling, and computer-aided trial design.
  arXiv  Detail & Related papers  (2022-09-16T14:59:31Z)
• Adaptive Identification of Populations with Treatment Benefit in Clinical Trials: Machine Learning Challenges and Solutions [78.31410227443102]
  We study the problem of adaptively identifying patient subpopulations that benefit from a given treatment during a confirmatory clinical trial. We propose AdaGGI and AdaGCPI, two meta-algorithms for subpopulation construction.
  arXiv  Detail & Related papers  (2022-08-11T14:27:49Z)
• Optimal personalised treatment computation through in silico clinical trials on patient digital twins [0.0]
  We present methods and an algorithm that, by means of extensive computer simulation--based experimental campaigns (ISTC) guided by intelligent search, optimise a pharmacological treatment for an individual patient (precision medicine) e show the effectiveness of our approach on a case study involving a real pharmacological treatment, namely the downregulation phase of a complex clinical protocol for assisted reproduction in humans.
  arXiv  Detail & Related papers  (2021-06-20T12:12:36Z)
• Learning for Dose Allocation in Adaptive Clinical Trials with Safety Constraints [84.09488581365484]
  Phase I dose-finding trials are increasingly challenging as the relationship between efficacy and toxicity of new compounds becomes more complex. Most commonly used methods in practice focus on identifying a Maximum Tolerated Dose (MTD) by learning only from toxicity events. We present a novel adaptive clinical trial methodology that aims at maximizing the cumulative efficacies while satisfying the toxicity safety constraint with high probability.
  arXiv  Detail & Related papers  (2020-06-09T03:06:45Z)
• Contextual Constrained Learning for Dose-Finding Clinical Trials [102.8283665750281]
  C3T-Budget is a contextual constrained clinical trial algorithm for dose-finding under both budget and safety constraints. It recruits patients with consideration of the remaining budget, the remaining time, and the characteristics of each group.
  arXiv  Detail & Related papers  (2020-01-08T11:46:48Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.